ALVMG — Visiomed SA Share Price
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeSmall CapSucker Stock
- €98.70m
- €104.63m
- €14.45m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.32 | ||
| Price to Tang. Book | 27.74 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 8.19 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -10.68% | ||
| Return on Equity | -14.08% | ||
| Operating Margin | -28.11% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 8.74 | 10.24 | 18.98 | 7.17 | 14.45 | 13 | 18.3 | 6.67% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Visiomed Group SA is a France-based company. The Company is primarily engaged in the design, manufacture and marketing of medical electronics. It develops and markets health products in the fields of medical and well-being self-diagnosis to provide non-drug prevention and treatment solutions. The Company's product portfolio comprises MyThermo, an infrared contact-less medical thermometer; MyTension, an automatic blood pressure and pulse monitors; MyOxy, a finger pulse oximeter; MyECG, a pocket electrodiogram; MyGluco, a blood sugar meter; My Coach, a health and fitness coach, and Epiderm, a telemedicine dermatology mobile application, among others. The Company serves pharmacies, health professionals, hospitals, clinics and retirement homes. It also offers connected solutions and COVID devices such as deconfinement kits, masks, filter cushion, serological tests etc. The Company’s subsidiaries include ThermoFlash and BewellConnect.
Directors
- Patrick Schiltz CHM
- Michel Emelianoff DCE
- Sebastien De Blegiers DRC (42)
- Yves Desiront DRC
- Frederic Paul DRC
- Last Annual
- December 31st, 2022
- Last Interim
- June 30th, 2023
- Incorporated
- August 10th, 2009
- Public Since
- July 5th, 2011
- No. of Employees
- 73
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Euronext - Paris
- Shares in Issue
- 294,268,628
- Address
- 74 rue Blanche, PARIS, 75009
- Web
- https://www.visiomed-group.com/
- Phone
- +33 180272990
- Contact
- Jerome Fabreguettes-leib
- Auditors
- EXAFI Conseil Audit & Expertise
Upcoming Events for ALVMG
Similar to ALVMG
Affluent Medical SAS
Euronext - Paris
Alpha MOS SA
Euronext - Paris
Amplitude Surgical SA
Euronext - Paris
Biomerieux SA
Euronext - Paris
Biosynex SA
Euronext - Paris
FAQ
What is the Visiomed SA share price?
As of Today at 18:23 UTC, shares in Visiomed SA are trading at €0.34. This share price information is delayed by 15 minutes.
How has the Visiomed SA share price performed this year?
Shares in Visiomed SA last closed at €0.34 and the price had moved by -24.97% over the past 365 days. In terms of relative price strength the Visiomed SA share price has underperformed the FTSE Global All Cap Index by -28.25% over the past year.
What are the analyst and broker recommendations for Visiomed SA?
The overall consensus recommendation for Visiomed SA is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Visiomed SA dividend yield?
Visiomed SA does not currently pay a dividend.
Does Visiomed SA pay a dividend?
Visiomed SA does not currently pay a dividend.
When does Visiomed SA next pay dividends?
Visiomed SA does not currently pay a dividend.
How do I buy Visiomed SA shares?
To buy shares in Visiomed SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Visiomed SA?
As of the previous close price of €0.34, shares in Visiomed SA had a market capitalisation of €98.70m.
Where are Visiomed SA shares listed?
Here are the trading details for Visiomed SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: ALVMG
What kind of share is Visiomed SA?
Based on an overall assessment of its quality, value and momentum Visiomed SA is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Visiomed SA share price forecast for 2023?
The analyst consensus target price for shares in Visiomed SA is €0.70. That is 108.71% above the last closing price of €0.34.
Analysts covering Visiomed SA currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
What is the trend in the Visiomed SA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Visiomed SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -23.02%.
As of the last closing price of €0.34, shares in Visiomed SA were trading -16.77% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Visiomed SA PE Ratio?
The Visiomed SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €0.34.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Visiomed SA?
Visiomed SA's management team is headed by:
- Patrick Schiltz - CHM
- Michel Emelianoff - DCE
- Sebastien De Blegiers - DRC
- Yves Desiront - DRC
- Frederic Paul - DRC